These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 33455997)

  • 1. Autoantibodies Against ApoB-100 as a New Marker of Coronary Vulnerable Plaque.
    Egusa G
    J Atheroscler Thromb; 2021 Oct; 28(10):1020-1022. PubMed ID: 33455997
    [No Abstract]   [Full Text] [Related]  

  • 2. Relationship of Autoantibodies to MDA-LDL and ApoB-Immune Complexes to Sex, Ethnicity, Subclinical Atherosclerosis, and Cardiovascular Events.
    Prasad A; Clopton P; Ayers C; Khera A; de Lemos JA; Witztum JL; Tsimikas S
    Arterioscler Thromb Vasc Biol; 2017 Jun; 37(6):1213-1221. PubMed ID: 28473443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoantibodies to oxidized low density lipoprotein in relation with coronary artery disease.
    Soto Y; Conde H; Aroche R; Brito V; Luaces P; Nasiff A; Obregón A; Vázquez López AM
    Hum Antibodies; 2009; 18(3):109-17. PubMed ID: 19729805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-Lipoprotein Lipase Antibody as a Useful Marker for Plaque Vulnerability in Patients with Stable Angina.
    Yoshinaga M; Yuasa E; Matsuoka T; Kihara S; Yamamoto H
    J Atheroscler Thromb; 2024 Jul; 31(7):1087-1097. PubMed ID: 38325861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apolipoprotein B-100 Antibody Interaction With Atherosclerotic Plaque Inflammation and Repair Processes.
    Asciutto G; Wigren M; Fredrikson GN; Mattisson IY; Grönberg C; Alm R; Björkbacka H; Dias NV; Edsfeldt A; Gonçalves I; Nilsson J
    Stroke; 2016 Apr; 47(4):1140-3. PubMed ID: 26965851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoantibodies to malondialdehyde-modified low-density lipoprotein in patients with angiographically confirmed coronary artery disease.
    McDowell A; Young IS; Wisdom GB
    J Pharm Pharmacol; 2002 Dec; 54(12):1651-7. PubMed ID: 12542895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-Apo B-100 Autoantibody is a Marker of Unstable Coronary Plaque.
    Imai M; Kawamura M; Kochi I; Matsuoka T; Kihara S; Yamamoto H
    J Atheroscler Thromb; 2021 Oct; 28(10):1025-1034. PubMed ID: 33191364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High plasma concentrations of autoantibodies against native peptide 210 of apoB-100 are related to less coronary atherosclerosis and lower risk of myocardial infarction.
    Sjögren P; Fredrikson GN; Samnegard A; Ericsson CG; Ohrvik J; Fisher RM; Nilsson J; Hamsten A
    Eur Heart J; 2008 Sep; 29(18):2218-26. PubMed ID: 18664466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The intravenous injection of oxidized LDL- or Apolipoprotein B100--Coupled splenocytes promotes Th1 polarization in wildtype and Apolipoprotein E--Deficient mice.
    Steinmetz M; Ponnuswamy P; Laurans L; Esposito B; Tedgui A; Mallat Z
    Biochem Biophys Res Commun; 2015 Aug; 464(1):306-11. PubMed ID: 26116775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Lipoprotein(a), its autoantibodies, and circulating T lymphocyte subpopulations as independent risk factors for coronary artery atherosclerosis].
    Afanasievа OI; Pylaeva EA; Klesareva EA; Potekhina AV; Provatorov SI; Afanasieva MI; Krasnikova TL; Masenko VP; Arefieva TI; Pokrovsky SN
    Ter Arkh; 2016; 88(9):31-38. PubMed ID: 27735911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of IgG antibodies to oxidized LDL in patients with acute coronary syndrome.
    Laczik R; Szodoray P; Veres K; Szomják E; Csípo I; Sipka S; Shoenfeld Y; Szekanecz Z; Soltész P
    Lupus; 2011 Jun; 20(7):730-5. PubMed ID: 21505011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of D-dimer with Plaque Characteristics and Plasma Biomarkers of Oxidation-Specific Epitopes in Stable Subjects with Coronary Artery Disease.
    Kothari H; Nguyen AT; Yang X; Hisada Y; Tsimikas S; Mackman N; Taylor A; McNamara CA
    J Cardiovasc Transl Res; 2018 Jun; 11(3):221-229. PubMed ID: 29344841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccination to modulate atherosclerosis.
    Kimura T; Tse K; Sette A; Ley K
    Autoimmunity; 2015 May; 48(3):152-60. PubMed ID: 25683179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unique antibody responses to malondialdehyde-acetaldehyde (MAA)-protein adducts predict coronary artery disease.
    Anderson DR; Duryee MJ; Shurmur SW; Um JY; Bussey WD; Hunter CD; Garvin RP; Sayles HR; Mikuls TR; Klassen LW; Thiele GM
    PLoS One; 2014; 9(9):e107440. PubMed ID: 25210746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associations between autoantibodies against apolipoprotein B-100 peptides and vascular complications in patients with type 2 diabetes.
    Fredrikson GN; Anand DV; Hopkins D; Corder R; Alm R; Bengtsson E; Shah PK; Lahiri A; Nilsson J
    Diabetologia; 2009 Jul; 52(7):1426-33. PubMed ID: 19448981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship of IgG and IgM autoantibodies to oxidized low density lipoprotein with coronary artery disease and cardiovascular events.
    Tsimikas S; Brilakis ES; Lennon RJ; Miller ER; Witztum JL; McConnell JP; Kornman KS; Berger PB
    J Lipid Res; 2007 Feb; 48(2):425-33. PubMed ID: 17093289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low levels of IgG autoantibodies against the apolipoprotein B antigen p210 increases the risk of cardiovascular death after carotid endarterectomy.
    Asciutto G; Dias NV; Edsfeldt A; Alm R; Fredrikson GN; Gonçalves I; Nilsson J
    Atherosclerosis; 2015 Apr; 239(2):289-94. PubMed ID: 25682025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoantibodies against modified low-density lipoproteins in coronary artery disease.
    Tornvall P; Waeg G; Nilsson J; Hamsten A; Regnström J
    Atherosclerosis; 2003 Apr; 167(2):347-53. PubMed ID: 12818418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent Advances in Fluorescent Angioscopy for Molecular Imaging of Human Atherosclerotic Coronary Plaque.
    Uchida Y
    J Atheroscler Thromb; 2017 Jun; 24(6):539-551. PubMed ID: 28381766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atherogenicity of autoantibodies against low density lipoprotein.
    Orekhov AN; Tertov VV
    Agents Actions; 1991 Jan; 32(1-2):128-9. PubMed ID: 2058460
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.